InvestorsHub Logo
Followers 20
Posts 1734
Boards Moderated 0
Alias Born 06/29/2009

Re: None

Wednesday, 04/07/2021 7:51:34 AM

Wednesday, April 07, 2021 7:51:34 AM

Post# of 199850
I’m not even going to bother looking at the share price anymore until the stock gets off the pinks. The bottom line is for now we’re just like most other pink sheet stocks. We’re good for a flip on news and that’s it. We have no real revenue and/or products. I believe the company is legit based on recent activity, but the stock still sucks and it will until they up list, get government funding, sign a partnership, or receive a buyout offer. Those things will legitimize it and we can then move higher. The financials were solid, the attorney letter was a step in the right direction, and the latest PR was great news. We got one solid day and after the first two hours yesterday the volume died off and the selling and shorting resumed. That’s what we’ll continue to see for now. We’ll likely fall back into the teens until the next PR and get another spike towards $.25-$.30 with no follow through until the up list and other big news hits. The future should be solid, but for now we’re being viewed as just another stinky pinky. People aren’t willing to hold this or most OTC stocks for any length of time right now. Plus, I still fear that the big pharmaceutical companies would rather just crush this company rather than partner with them if it’s better for them financially to keep selling inadequate vaccines and medicine. I hope I'm wrong.

DO YOUR OWN DD! THIS POST IS MY OPINION ONLY! DO NOT USE AS TRADING ADVISE!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News